Conditions may worsen for households already under mortgage stress, with a new report predicting mortgage delinquency rates will increase over the next year.
WA’s corporate community needs to “put runs on the board” to effectively tackle inclusion and diversity in the workplace, says WA’s female business leaders.
Australians with Multiple Sclerosis will have access to a life-saving medicine for as little as $41 per prescription.
The coronavirus pandemic has fundamentally changed the nature of the workforce, with many organisations choosing to take out the middle man and opt to hire freelancers, experts say.
The Federal Government could pour hundreds of millions of dollars into its own COVID-19 vaccine technology, despite being offered a free IT platform from one of the world’s biggest software firms.
The pharmaceutical giant will walk away from its more than 50-year-old facility in Perth, leaving 470 local jobs at risk.
WA’s hard border is starting to create an uneven playing field among the State’s business community, with some companies adversely impacted, while others are reaping the benefits.
WA-founded biotech company Recce Pharmaceuticals has secured ethics approval to trial one of its drugs on Perth patients with infected burns wounds.
Danielle Le Messurier
The Federal and State Budgets failed to provide adequate support to females in the workforce, with WA leaders calling for “bolder aspirations to help create a fairer society”.
The resilience of WA businesses throughout the COVID pandemic has resulted in further support potentially being held back in WA State Budget, but experts say it is not a negative thing.
Perth-based precision medicine company PYC Therapeutics has developed a new drug to treat the two leading causes of blindness.
Bunnings boss Mike Schneider believes support for staff’s mental wellbeing is increasingly crucial.
WA captains of industry stand ready to engage with the McGowan Government, and are pushing for bold thinking as pressure points begin to emerge among various sectors.
Business sentiment is shifting towards the reopening of the State’s border, say WA’s industry leaders, with an increasing need for clarity becoming harder to ignore.
Shares in the Australian biotech Mesoblast plunged after US health authorities did not approve its therapy to treat a rare disease.
Market heavyweight CSL is facing increased price pressure as it deals with rising competition in the global health care sector.
Using e-cigarettes triples the chance of a non-smoker taking up conventional cigarettes, new research shows.
Consumer confidence has risen for a fourth straight week in anticipation of a big-spending federal budget next week.
Boeing has designed an ultraviolet wand — be manufactured by Florida-based Healthe — to sanitise aircraft.
WA’s biggest private health insurer says members are now also pulling forward planned procedures from next year
The redevelopment — which will add an emergency department and a new mother and baby centre — will see the first buildings built on the Subiaco complex for more than 25 years.
State has unique opportunity to develop a thriving medi-tech sector amid coronavirus, but must grasp its chances.
Perth-based medicinal cannabis company Cannaponics has raised $1.5 million in its first round of seed capital as it works to develop a $15m cannabis and hemp hub in Collie.
A new app is helping WA bosses break down mental health barriers with employees, with many at increased risk of burnout because of the pandemic.
© West Australian Newspapers Limited 2020